AtaiBeckley To Participate in Upcoming Investor Conferences
AtaiBeckley To Participate in Upcoming Investor Conferences is drawing significant interest across the industry.
NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) ('AtaiBeckley” or 'Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced that Srinivas Rao, M.D., Ph.D., Co-Founder and Chief Executive Officer, and Jason Awe, Ph.D., Vice President of Investor Relations, will participate in fireside chats and host one-on-one meetings at the following investor conferences in March.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Why living in your childhood bedroom in your late 20s in no longer a failure
- Top-seeded Gonzaga hoping to take 'next jump' in WCC semifinal against fourth-seeded Oregon State
- White House targets tech giants to shield consumers from AI’s power costs
- Iran war and Ukraine: How conflict is affecting peace talks, oil prices and weapons supplies
Source: Original →